Literature DB >> 1807361

Is there a solution for recurrent endometriosis?

J L Evers1, G A Dunselman, J A Land, P X Bouckaert.   

Abstract

Endometriosis may be either symptomatic or asymptomatic. Recurrence rates are mostly calculated on the basis of symptomatic patients re-presenting to their doctor. Based on the number of patients who experience recurrence of symptoms after medical or surgical therapy, recurrence rates of up to 45% after five years have been calculated. Whether the symptoms are due to real recurrence of disease or expanding, previously microscopic, endometriotic implants has not yet been established. Therapy should be tailored to the patient's complaints, but does not necessarily have to differ from that in patients with primary disease.

Entities:  

Mesh:

Year:  1991        PMID: 1807361

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN: 0262-8767


  7 in total

1.  Risk Factors for Endometriosis in a German Case-Control Study.

Authors:  S Burghaus; P Klingsiek; P A Fasching; A Engel; L Häberle; P L Strissel; M Schmidt; K Jonas; J D Strehl; A Hartmann; J Lermann; A Boosz; F C Thiel; A Müller; M W Beckmann; S P Renner
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

Review 2.  The elusive and controversial roles of estrogen and progesterone receptors in human endometriosis.

Authors:  Ruijin Shao; Shujun Cao; Xiaoqin Wang; Yi Feng; Håkan Billig
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

3.  Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†.

Authors:  Nikola Sekulovski; Allison E Whorton; Mingxin Shi; James A MacLean; Kanako Hayashi
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

Review 4.  Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Authors:  Mi-La Kim; Seok Ju Seong
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

5.  Niclosamide suppresses macrophage-induced inflammation in endometriosis†.

Authors:  Nikola Sekulovski; Allison E Whorton; Tomoki Tanaka; Yasushi Hirota; Mingxin Shi; James A MacLean; Julio Ricardo Loret de Mola; Kathleen Groesch; Paula Diaz-Sylvester; Teresa Wilson; Kanako Hayashi
Journal:  Biol Reprod       Date:  2020-04-24       Impact factor: 4.285

6.  Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model.

Authors:  Genna R Prather; James A MacLean; Mingxin Shi; Daniel K Boadu; Marilène Paquet; Kanako Hayashi
Journal:  Biol Reprod       Date:  2016-08-17       Impact factor: 4.285

Review 7.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.